The White House Office of Management and Budget unveiled a proposed rule Wednesday (July 27) that aims to advance the administration’s goal of returning critical supply chains, including those for drugs and medical supplies, to the United States by increasing production of active pharmaceutical ingredients and offering price preferences for domestic products. White House officials said the proposed rule is just the first step the administration plans to take in strengthening domestic manufacturing. Under the proposed rule, at least 60%...